Stalevo 75 Interactions
There are 534 drugs known to interact with Stalevo 75 (carbidopa/entacapone/levodopa), along with 14 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 50 are major, 472 are moderate, and 12 are minor.
- View all 534 medications that may interact with Stalevo 75
- View Stalevo 75 alcohol/food interactions (2)
- View Stalevo 75 disease interactions (14)
Most frequently checked interactions
View interaction reports for Stalevo 75 (carbidopa / entacapone / levodopa) and the medicines listed below.
- amantadine
- Azilect (rasagiline)
- Celebrex (celecoxib)
- clonazepam
- Coumadin (warfarin)
- doxazosin
- Flomax (tamsulosin)
- fludrocortisone
- hydrocodone
- ibuprofen
- Klonopin (clonazepam)
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- magnesium oxide
- metoprolol
- Mucinex (guaifenesin)
- Neupro (rotigotine)
- omeprazole
- Plavix (clopidogrel)
- Requip XL (ropinirole)
- risperidone
- ropinirole
- Skelaxin (metaxalone)
- Symmetrel (amantadine)
- tizanidine
- tramadol
- Tylenol Arthritis Pain (acetaminophen)
- Vitamin C (ascorbic acid)
Stalevo 75 alcohol/food interactions
There are 2 alcohol/food interactions with Stalevo 75 (carbidopa / entacapone / levodopa).
Stalevo 75 disease interactions
There are 14 disease interactions with Stalevo 75 (carbidopa / entacapone / levodopa) which include:
- glaucoma
- cardiac disease
- neuroleptic malignant syndrome
- psychoses/depression
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- sleep disorders
- hypotension
- psychosis
- hepatic impairment
- GI bleeding
Report options
More about Stalevo 75 (carbidopa / entacapone / levodopa)
- Stalevo 75 consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: dopaminergic antiparkinsonism agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
